Researchers have developed DIASENTINEL, a novel multi-agent system designed for on-premise screening of type 2 diabetes risk using electronic health records (EHRs). This system aims to address the challenges of LLM hallucinations and citation errors in clinical decision support. DIASENTINEL integrates calibrated risk prediction, clinical signal extraction, and a verification layer that combines rule-based checks with LLM entailment, all grounded in American Diabetes Association guidelines. The system provides a dashboard for real-time screening and an interactive interface for patient reports, complete with cited recommendations and verification results. AI
IMPACT This system offers a framework for auditable and privacy-preserving LLM-based clinical decision support, potentially improving the reliability of AI in healthcare.
RANK_REASON The cluster contains a research paper detailing a new system for clinical decision support. [lever_c_demoted from research: ic=1 ai=1.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →